COVID-19

Mayo Clinic researchers and collaborators report that persistent lung changes after COVID-19 in patients over 60 may be linked to specific populations of T cells. ...

Los investigadores de Mayo Clinic y sus colaboradores usaron simulación por computadora e inteligencia artificial (IA) para seleccionar 30 millones de posibles fármacos que obstruyan ...

No champion race car driver can win without a dedicated pit crew. The same is true in medical research. Thanks to their “pit crew” Mayo ...

Experimental Treatment Pivots in Record Time At the beginning of 2020, everyone in research and medicine who could pivot to focus on COVID-19 did. Scientists and ...

Mayo Clinic researchers and collaborators used computer simulation and artificial intelligence to virtually screen 30 million drug candidates that may block SARS-CoV-2, the virus that ...

Humanity has taken on infectious agents, such as the virus that causes smallpox, and won. But cheer quietly. Smallpox eradication took 200 years, and it's ...

A year after the first case of COVID-19 was reported in the U.S., more than 26 million Americans are confirmed to have had this disease, ...

Current experimental treatments for COVID-19 focus on two targets: the virus or the immune system.  On the immune system side, the number of experimental treatments ...

While the SARS-CoV-2 virus that causes COVID-19 continues to evolve, there are vaccines developed so far that prevent severe COVID-19. However, they approach their goal ...

On Thursday, Nov. 19, Mayo Clinic began offering an experimental therapy to patients who test positive for COVID-19 and are at high risk for serious ...